Introduction
============

Castleman\'s disease is a rare benign disorder of unknown etiology characterized by proliferation of lymphoid tissues ([@b1-mco-0-0-1963]). Although Castleman\'s disease has been found in lymphatic tissues of the chest, neck, abdomen, and pelvis, its retroperitoneal localization is rare; further, its localization in the pelvic retroperitoneum is extremely rare ([@b2-mco-0-0-1963],[@b3-mco-0-0-1963]). To date, only 14 cases of retroperitoneal localization of Castleman\'s disease occurring in female pelvis have been documented in the English literature ([Table I](#tI-mco-0-0-1963){ref-type="table"}) ([@b4-mco-0-0-1963]). The pre-operative diagnosis of pelvic retroperitoneal Castleman\'s disease is difficult, and most cases have been diagnosed based on post-operative pathological examination. Furthermore, due to the limited number of cases described, the appropriate clinical management strategy for this disease is not yet established. Herein, we report a rare case of Castleman\'s disease localized in the female pelvic retroperitoneum, which was completely resected by laparoscopic surgery.

Case report
===========

A 47-year-old gravida 5, para 3 female was referred to our hospital because of a pelvic mass accidentally found by radiological examination at a health checkup. She had no systemic symptoms such as pelvic pain, fatigue, fever, or weight loss. Transvaginal ultrasound examination revealed a 7.8 cm-sized simple cystic tumor on the left ovary. Magnetic resonance imaging (MRI) revealed an 8.2 cm-sized ovarian cyst and a 5.2 cm-sized heterogeneously hyper-enhanced solid tumor in the retroperitoneal space of the left pelvis on T2-weighted (T2W) images ([Fig. 1A](#f1-mco-0-0-1963){ref-type="fig"}). On T1-weighted (T1W) images, the pelvic retroperitoneal tumor was homogeneous and nearly isointense to uterus in signal intensity. Computed tomography (CT) revealed partial calcification of both the cystic and solid pelvic retroperitoneal tumors, with no pelvic lymph node swelling ([Fig. 1B](#f1-mco-0-0-1963){ref-type="fig"}). ^18^F-fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography (FDG-PET/CT) detected high radiotracer uptake by the retroperitoneal tumor \[maximum standardized uptake value (SUVmax): 4.14\], with no distant metastases ([Fig. 1C](#f1-mco-0-0-1963){ref-type="fig"}). Serum levels of carcinoembryonic antigen (CEA), cancer antigen (CA) 19-9, CA125, and interleukin 6 (IL-6) were within the normal range. Except for the above-mentioned findings, serum biochemical and clotting studies were within the normal limits.

A laparoscopic surgery was performed for both pelvic retroperitoneal tumor and left ovarian cyst. Intraoperative examination evidenced that the pelvic retroperitoneal tumor was most likely to represent a lymph node enlargement at the left external iliac area and was associated with mobile and smooth left ovarian tumor ([Fig. 2A](#f2-mco-0-0-1963){ref-type="fig"}). A laparoscopic monopolar device was applied to excise the pelvic peritoneum and expose the pelvic mass, and a bipolar device was subsequently applied to ensure coagulation around the tumor. Although it was closely located to the external iliac vessels, no direct vascular invasion was noted in the tumor and its surface was well circumscribed ([Fig. 2B](#f2-mco-0-0-1963){ref-type="fig"}). This way, tissues around the tumor could be dissected and the feeding vessel desiccated from the external iliac artery with limited bleeding. No enlarged lymph nodes were found at the retroperitoneal region. These tumors were placed in a plastic bag and removed through the umbilical trocar site.

Macroscopically, the pelvic retroperitoneal tumor was rubbery firm, with the cut surface appearing soft, finely granular, and pale yellow in color ([Fig. 2C](#f2-mco-0-0-1963){ref-type="fig"}). Microscopic examination revealed marked follicular hyperplasia with concentric layering of mantle-zone lymphocytes ([Fig. 3](#f3-mco-0-0-1963){ref-type="fig"}). Most follicles were hyalinized and atrophic, with an expanded follicular dendritic cell network. Paraffin section immunostain showed mixed populations of CD20-immunoreactive B cells and CD3-immunoreactive T cells and negative staining for immunoglobulin G4 (IgG4) (data not shown). The pathological diagnosis was unicentric and hyaline vascular type of Castleman\'s disease localized in the pelvic retroperitoneum. The cystic tumor in the left ovary was diagnosed as a benign simple cyst. The postoperative course was uneventful, and the patient was discharged from the hospital on postoperative day 5. Six months after diagnosis, there was no evidence of local recurrence or systemic disease.

Discussion
==========

The present case refers to an incidentally found unicentric and hyaline vascular type of Castleman\'s disease localized in the pelvic retroperitoneum, with no symptoms. Castleman\'s disease is a rare, benign lymphoproliferative disorder originally described by Castleman and Towne in 1954([@b18-mco-0-0-1963]). Castleman\'s disease includes unicentric and multicentric forms, which are thought to represent distinct clinical entities with different risk factors, presentation, treatment response, and long-term survival ([@b19-mco-0-0-1963]). The most common-unicentric-form, is often found in both males and females aged 20-30 years and presents asymptomatically or with compressive symptoms related to the mass ([@b20-mco-0-0-1963]). Unicentric Castleman\'s disease affects a single group of lymph nodes, often in the chest or abdomen, and is generally cured with surgical resection of the involved group of lymph nodes ([@b19-mco-0-0-1963]). Multicentric Castleman\'s disease is more often found in adults aged 50-60 years and is likely to present with systemic symptoms, including fever, malaise, night sweats, weakness, weight loss, and peripheral lymphadenopathy ([@b20-mco-0-0-1963]). Multicentric Castleman\'s disease may also be found in immunosuppressed patients infected with HIV and human herpesvirus 8([@b21-mco-0-0-1963]). Multicentric Castleman\'s disease tends to behave aggressively, similarly to a lymphoma, and is less likely to be cured by surgical resection ([@b19-mco-0-0-1963]). Castleman\'s disease can also be grouped into hyaline vascular and plasma cell types according to histopathological subsets ([@b22-mco-0-0-1963]). The hyaline vascular type accounts for 90% of cases. Recently, a mixed type of hyaline vascular and plasma cell types has also been reported ([@b23-mco-0-0-1963]).

Preoperative diagnosis of Castleman\'s disease-especially when located in the pelvis-is difficult due to its very low frequency and nonspecific radiographic signs. Benign retroperitoneal tumors are relatively uncommon, comprising only approximately 20% of all primary retroperitoneal neoplasms ([@b24-mco-0-0-1963]). The differential diagnosis of a retroperitoneal mass includes lymphoma, sarcoma, metastasis, neural tumor, and granulomatous disease ([@b2-mco-0-0-1963]). Among these entities, lymphoma is the most difficult to distinguish from Castleman\'s disease because of its similar homogeneity on radiographic findings. CT generally demonstrates a homogeneous soft tissue mass, and both histological types of Castleman\'s disease show contrast enhancement ([@b25-mco-0-0-1963]). Variable patterns of calcification can be seen in CT in up to 31% of cases, including the present one ([@b25-mco-0-0-1963]). On MRI, unicentric Castleman\'s disease exhibits mild hyperintensity in T1W and T2W imaging compared with skeletal muscle ([@b26-mco-0-0-1963]). MRI is particularly suitable to evaluate the extent of the lesion and its relationship to adjacent structures, but it is less sensitive to calcifications ([@b2-mco-0-0-1963]). In FDG-PET/CT, Castleman\'s disease demonstrates only moderate radiotracer uptake with reported SUVmax between 4.7 and 5.8 ([@b27-mco-0-0-1963],[@b28-mco-0-0-1963]). Most active lymphomas express much higher average SUVs than FDG-avid lymph nodes in Castleman\'s disease ([@b29-mco-0-0-1963],[@b30-mco-0-0-1963]); however, some degree of overlap with low- and intermediate-grade lymphoma is possible. Murphy *et al* ([@b30-mco-0-0-1963]) emphasized that, in several cases of low- and intermediate-grade lymphomas, SUVs are higher than those found in Castleman\'s disease. Retroperitoneal sarcoma and lymphoma are more likely to demonstrate higher apparent diffusion coefficient values (ADC) on MRI ([@b31-mco-0-0-1963]) and higher ^18^F-FDG avidity (SUVmax, 4.2-23.6) on PET/CT ([@b32-mco-0-0-1963]). In the present case, MRI allowed us to conclude that the mass was located on the retroperitoneal space and not in the ovary, and FDG-PET/CT helped to narrow down the differential diagnosis, particularly considering lymphoma and sarcoma.

In the English literature, a small number of Castleman\'s disease cases have been reported in the female pelvis ([@b4-mco-0-0-1963]), with clinical characteristics resembling a tubo-ovarian abscess, endometriotic cyst, or dermoid cyst of ovarian origin. The mean age and tumor size of Castleman\'s disease cases were 26.5 (13-58) and 7.5 cm (5.0-10.0 cm), respectively ([Table I](#tI-mco-0-0-1963){ref-type="table"}). Due to the low incidence of Castleman\'s disease in the female pelvis and the clinical resemblances with other pelvic masses, it may be difficult to diagnose Castleman\'s disease in initial evaluation and the case may be included in the differential diagnosis of pelvic mass. In most cases, pelvic Castleman\'s disease presents as a pelvic mass with clinical suspicion of adnexal tumor. Fortunately, this case of pelvic retroperitoneal Castleman\'s disease was associated with an ipsilateral benign ovarian cyst, which also helped to diagnose the mass as retroperitoneal-and not ovarian-in origin. Castleman\'s disease is an important consideration in the differential diagnosis of pelvic masses in women.

The appropriate clinical management strategy for pelvic retroperitoneal Castleman\'s disease has not been established, as clinical experience with such cases is limited. While only limited successful management with steroids and cytotoxic agents has been reported ([@b33-mco-0-0-1963]), surgical excision has been considered as standard therapy. A wide, complete excisional margin is preferred due to the lesion\'s infiltrative pattern and potential for recurrence. Incomplete resection may be associated with poorer outcome ([@b34-mco-0-0-1963]). Although Castleman\'s disease has a benign histology, surgical excision is not always easy. As observed in the present case, hypervascularity is frequently associated with massive hemorrhage at excision. Pelvic retroperitoneal Castleman\'s disease is often accompanied by remarkable fibrous adhesion to the surrounding tissues ([@b35-mco-0-0-1963]). To avoid massive hemorrhage, it is essential to fully dissect tissues around the tumor and have enough space to desiccate the feeding vessel originated from large vessel. A thorough pre-operative discussion about radiological examination could be useful for assisting the preparation for surgical resection. Although several cases of unicentric Castleman\'s disease in the abdominal cavity treated laparoscopically have been reported ([@b36-mco-0-0-1963],[@b37-mco-0-0-1963]), to the best of our knowledge, only one report on female pelvic retroperitoneal Castleman\'s disease treated by laparoscopy is available in literature ([Table I](#tI-mco-0-0-1963){ref-type="table"}) ([@b16-mco-0-0-1963]). As some masses are well vascularized and adjacent to the great vessels, laparoscopy can provide magnified images that facilitate and secure dissection.

In summary, a rare case of female pelvic retroperitoneal Castleman\'s disease was found, for which a laparoscopic surgery was performed. Gynecologists should be aware of the possible event of such rare cases, and available surgical interventions should be fully discussed. Laparoscopic surgery may be a possible treatment option for such a rare condition.
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![Radiological findings of pelvic retroperitoneal Castleman\'s disease. Arrowheads indicate retroperitoneal tumor. Arrows indicate ovarian cyst. (A) T2-weighted magnetic resonance imaging findings. (B) Computed tomography findings. (C) ^18^F-fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography findings.](mco-12-02-0169-g00){#f1-mco-0-0-1963}

![Laparoscopic and macroscopic findings of pelvic retroperitoneal Castleman\'s disease. Arrowheads indicate retroperitoneal tumor. Arrows indicate ovarian cyst. (A) Left retroperitoneal tumor and left ovarian tumor. (B) Retroperitoneal tumor surface. (C) Cut surface of retroperitoneal tumor macroscopic findings.](mco-12-02-0169-g01){#f2-mco-0-0-1963}

![Microscopic findings of pelvic retroperitoneal Castleman\'s disease. Hematoxylin and eosin staining. (A) Magnification, x4; and (B) magnification, x20. Arrowheads indicate hyalinization.](mco-12-02-0169-g02){#f3-mco-0-0-1963}

###### 

Previously reported cases of Castleman\'s disease in the female pelvic retroperitoneum since 1962 in English literature.

  Author, year                 Age, years      Disease site              Tumor size        Treatment                (Refs.)
  ---------------------------- --------------- ------------------------- ----------------- ------------------------ -----------------------
  Latters and Pachter, 1962    29              Pre-sacral                5.0x2.5x2.0 cm    Abdominal resection      ([@b4-mco-0-0-1963])
  Giaretta *et al*, 1971       37              Para-iliac vessel         9.0 cm            Abdominal resection      ([@b5-mco-0-0-1963])
  Emson, 1973                  14              Para-iliac vessel         not specified     Abdominal biopsy         ([@b6-mco-0-0-1963])
  Bainbridge 1976              21              Para-iliac vessel         8.0x5.0x4.0 cm    Abdominal resection      ([@b7-mco-0-0-1963])
  Tanaka *et al*, 1976         36              Para-iliac vessel         9.0x8.0x5.0 cm    Abdominal resection      ([@b8-mco-0-0-1963])
  Kumar *and Shah*, 1979       19              Adherent to ovary         10.0x9.0x3.0 cm   Abdominal resection      ([@b9-mco-0-0-1963])
  Goodman *et al*, 1983        17              Pre-sacral                8.0x5.0x4.0 cm    Abdominal resection      ([@b10-mco-0-0-1963])
  Ylinen *et al*, 1995         26              Retro pubic               5.0x4.0x4.0 cm    Abdominal resection      ([@b11-mco-0-0-1963])
  MacDonald *et al*, 1996      58              Sigmoid colon mesentery   8.0x4.0 cm        Abdominal resection      ([@b12-mco-0-0-1963])
  Gaunt *et al*, 2002          Not specified   Pre-sacral                6.0 cm            Abdominal resection      ([@b13-mco-0-0-1963])
  Nakamura *et al*, 2004       30              Para-iliac vessel         6.5x5.0x4.0 cm    Abdominal resection      ([@b14-mco-0-0-1963])
  Sato, 2013                   22              Para-sacral vessel        9.5x7.0x7.0 cm    Abdominal resection      ([@b15-mco-0-0-1963])
  Lee *et al*, 2015            27              Para-iliac vessel         7.0 cm            Laparoscopic resection   ([@b16-mco-0-0-1963])
  Schelble and Merritt, 2019   13              Pelvic side wall          5.5x3.5x2.0 cm    Abdominal resection      ([@b17-mco-0-0-1963])
  Present study                47              Para-iliac vessel         5.2 cm            Laparoscopic resection   \-
